Your browser doesn't support javascript.
loading
Pharmacological properties of revefenacin (TD-4208), a novel, nebulized long-acting, and lung selective muscarinic antagonist, at human recombinant muscarinic receptors and in rat, guinea pig, and human isolated airway tissues.
Hegde, Sharath S; Pulido-Rios, M Teresa; Luttmann, Mark A; Foley, James J; Hunsberger, Gerald E; Steinfeld, Tod; Lee, TaeWeon; Ji, Yuhua; Mammen, Mathai M; Jasper, Jeffrey R.
Afiliação
  • Hegde SS; Theravance Biopharma U.S, Inc South San Francisco CA USA.
  • Pulido-Rios MT; Theravance Biopharma U.S, Inc South San Francisco CA USA.
  • Luttmann MA; GlaxoSmithKline Pharmaceuticals King of Prussia PA USA.
  • Foley JJ; GlaxoSmithKline Pharmaceuticals King of Prussia PA USA.
  • Hunsberger GE; GlaxoSmithKline Pharmaceuticals King of Prussia PA USA.
  • Steinfeld T; Theravance Biopharma U.S, Inc South San Francisco CA USA.
  • Lee T; Theravance Biopharma U.S, Inc South San Francisco CA USA.
  • Ji Y; Theravance Biopharma U.S, Inc South San Francisco CA USA.
  • Mammen MM; Theravance Biopharma U.S, Inc South San Francisco CA USA.
  • Jasper JR; Theravance Biopharma U.S, Inc South San Francisco CA USA.
Pharmacol Res Perspect ; 6(3): e00400, 2018 06.
Article em En | MEDLINE | ID: mdl-29736245

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Traqueia / Benzamidas / Proteínas Recombinantes / Brônquios / Carbamatos / Antagonistas Muscarínicos Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Traqueia / Benzamidas / Proteínas Recombinantes / Brônquios / Carbamatos / Antagonistas Muscarínicos Idioma: En Ano de publicação: 2018 Tipo de documento: Article